TY - JOUR
T1 - Structure, folding dynamics, and amyloidogenesis of D76N β2-microglobulin roles of shear flow, hydrophobic surfaces, and α-crystallin
AU - Mangione, P. Patrizia
AU - Esposito, Gennaro
AU - Relini, Annalisa
AU - Raimondi, Sara
AU - Porcari, Riccardo
AU - Giorgetti, Sofia
AU - Corazza, Alessandra
AU - Fogolari, Federico
AU - Penco, Amanda
AU - Goto, Yuji
AU - Lee, Young Ho
AU - Yagi, Hisashi
AU - Cecconi, Ciro
AU - Naqvi, Mohsin M.
AU - Gillmore, Julian D.
AU - Hawkins, Philip N.
AU - Chiti, Fabrizio
AU - Rolandi, Ranieri
AU - Taylor, Graham W.
AU - Pepys, Mark B.
AU - Stoppini, Monica
AU - Bellotti, Vittorio
PY - 2013/10/25
Y1 - 2013/10/25
N2 - Systemic amyloidosis is a fatal disease caused by misfolding of native globular proteins, which then aggregate extracellularly as insoluble fibrils, damaging the structure and function of affected organs. The formation of amyloid fibrils in vivo is poorly understood. We recently identified the first naturally occurring structural variant, D76N, of human β2- microglobulin (β2m), the ubiquitous light chain of class I major histocompatibility antigens, as the amyloid fibril protein in a family with a new phenotype of late onset fatal hereditary systemic amyloidosis. Here we show that, uniquely, D76N β2mreadily forms amyloid fibrils in vitro under physiological extracellular conditions. The globular native fold transition to the fibrillar state is primed by exposure to a hydrophobic-hydrophilic interface under physiological intensity shear flow. Wild type β2m is recruited by the variant into amyloid fibrils in vitro but is absent from amyloid deposited in vivo. This may be because, as we show here, such recruitment is inhibited by chaperone activity. Our results suggest general mechanistic principles of in vivo amyloid fibrillogenesis by globular proteins, a previously obscure process. Elucidation of this crucial causative event in clinical amyloidosis should also help to explain the hitherto mysterious timing and location of amyloid deposition.
AB - Systemic amyloidosis is a fatal disease caused by misfolding of native globular proteins, which then aggregate extracellularly as insoluble fibrils, damaging the structure and function of affected organs. The formation of amyloid fibrils in vivo is poorly understood. We recently identified the first naturally occurring structural variant, D76N, of human β2- microglobulin (β2m), the ubiquitous light chain of class I major histocompatibility antigens, as the amyloid fibril protein in a family with a new phenotype of late onset fatal hereditary systemic amyloidosis. Here we show that, uniquely, D76N β2mreadily forms amyloid fibrils in vitro under physiological extracellular conditions. The globular native fold transition to the fibrillar state is primed by exposure to a hydrophobic-hydrophilic interface under physiological intensity shear flow. Wild type β2m is recruited by the variant into amyloid fibrils in vitro but is absent from amyloid deposited in vivo. This may be because, as we show here, such recruitment is inhibited by chaperone activity. Our results suggest general mechanistic principles of in vivo amyloid fibrillogenesis by globular proteins, a previously obscure process. Elucidation of this crucial causative event in clinical amyloidosis should also help to explain the hitherto mysterious timing and location of amyloid deposition.
UR - http://www.scopus.com/inward/record.url?scp=84886655678&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84886655678&partnerID=8YFLogxK
U2 - 10.1074/jbc.M113.498857
DO - 10.1074/jbc.M113.498857
M3 - Article
C2 - 24014031
AN - SCOPUS:84886655678
SN - 0021-9258
VL - 288
SP - 30917
EP - 30930
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 43
ER -